Concord Drugs P/B Ratio
Concord Drugs P/B ratio. Concord Drugs (CONCORD) P/B ratio is 2.17 (Moderate), book value per share ₹37.69 vs Healthcare average P/B of 0.01 — High - Premium to book value, growth expectations or asset-light model. Analyse CONCORD institutional holdings to track promoter, FII and institutional holdings.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
CONCORD P/B Ratio — Valuation Insights & Book Value Analysis
Concord Drugs price-to-book ratio interpretation, valuation status and historical context — current P/B 2.17 (Moderate). For live price, earnings yield and the full fundamental profile, see Concord Drugs share price screener.
- Current PB is 30.6% above historical average
- Trading at premium to sector average PB of 0.01
Concord Drugs P/B Ratio Historical Trend
CONCORD annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Concord Drugs yearly highs lows for the annual high/low range and current price position.
CONCORD Historical P/B Ratio — Book Value Per Share & Year-End Price
Concord Drugs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.04 | ₹37.69 | ₹76.92 | ₹49 | Moderate |
| 2025 | 2.43 | ₹34.0 | ₹82.48 | ₹34 | Moderate |
| 2024 | 1.11 | ₹34.0 | ₹37.70 | ₹34 | Moderate |
| 2023 | 1.68 | ₹35.56 | ₹59.72 | ₹32 | Moderate |
| 2022 | 1.05 | ₹31.11 | ₹32.55 | ₹28 | Moderate |
CONCORD vs Healthcare Peers — P/B Ratio Comparison
Concord Drugs P/B 2.17 vs Healthcare average 0.01, median 0.61 — range -6.55–1.07.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.19 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |